Other transepidermal elimination disorders
ICD-10 L87.8 is a billable code used to indicate a diagnosis of other transepidermal elimination disorders.
L87.8 refers to 'Other transepidermal elimination disorders,' which encompasses a range of skin conditions characterized by the abnormal elimination of substances through the epidermis. These disorders can manifest as various dermatological symptoms, including rashes, scaling, and lesions, often resulting from underlying systemic conditions or localized skin issues. The skin, being the largest organ, plays a crucial role in barrier function and immune response. In transepidermal elimination disorders, this function may be compromised, leading to increased permeability and altered skin homeostasis. Disease progression can vary; some conditions may be acute and self-limiting, while others can become chronic, requiring ongoing management. Diagnostic considerations include a thorough patient history, physical examination, and potentially skin biopsies or laboratory tests to rule out other dermatological conditions. Clinicians must differentiate L87.8 from related codes, such as L87.0 (ichthyosis) and L87.1 (acanthosis), to ensure accurate diagnosis and treatment.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
L87.8 includes various transepidermal elimination disorders such as certain forms of dermatitis, psoriasis, and other conditions where abnormal skin barrier function leads to excessive loss or retention of substances through the skin.
L87.8 should be used when the specific transepidermal elimination disorder does not fit the criteria for more defined conditions like ichthyosis (L87.0) or acanthosis (L87.1). It is essential to document the unique characteristics of the disorder to justify this code.
Documentation should include a detailed clinical history, physical examination findings, and any diagnostic tests performed. Specific notes on the nature of the skin lesions and their progression are crucial for supporting the use of L87.8.
